Evidence map›Paper›PMID 41890087›Full record

ArticlebioRxiv : the preprint server for biology2026

Neurogenin-2 Reprograms Human Microglial Lineage Cells into Neurons In Vitro and in Chimeric Brains.

Mengmeng Jin, Ziyuan Ma, Rui Dang, Haiwei Zhang, Haipeng Xue, Steven Finkbeiner, Ying Liu, Peng Jiang

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengmeng JinDepartment of Cell Biology and Neuroscience, Rutgers University New Brunswick, Piscataway, NJ 08854, USA.
Ziyuan MaDepartment of Cell Biology and Neuroscience, Rutgers University New Brunswick, Piscataway, NJ 08854, USA.
Rui DangDepartment of Cell Biology and Neuroscience, Rutgers University New Brunswick, Piscataway, NJ 08854, USA.
Haiwei ZhangDepartment of Cell Biology and Neuroscience, Rutgers University New Brunswick, Piscataway, NJ 08854, USA.
Haipeng XueDepartment of Environmental Health Sciences, Robert Stempel College of Public Health and Social Work, Center for Translational Science, Florida International University, Port St. Lucie, FL 34987, USA.
Steven FinkbeinerCenter for Systems and Therapeutics and the Taube/Koret Center for Neurodegenerative Disease, Gladstone Institutes, San Francisco, CA 94158, USA.ORCID 0000-0002-3480-394X
Ying LiuDepartment of Environmental Health Sciences, Robert Stempel College of Public Health and Social Work, Center for Translational Science, Florida International University, Port St. Lucie, FL 34987, USA.
Peng JiangDepartment of Cell Biology and Neuroscience, Rutgers University New Brunswick, Piscataway, NJ 08854, USA.ORCID 0000-0002-2650-3082

Funding

Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down SyndromeR01AG064579 · NIA · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2020 to 2024
$3.6M
A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down SyndromeR01AG073779 · NIA · RUTGERS, THE STATE UNIV OF N.J. · PI Peng Jiang · 2021 to 2026
$3.1M
Role of central and peripheral immune crosstalk in FTD-Grn neurodegenerationRF1NS128800 · NINDS · UNIVERSITY OF FLORIDA · PI FINKBEINER, STEVEN M, TANSEY, MARIA DE LOURDES GAMEZ · 2022 to 2022
$2.4M
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse ChimerasR01NS122108 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI Peng Jiang · 2021 to 2026
$2.1M
Reconnecting the injured cervical spinal cord by transplanted human iPSC-derived neural progenitorsR01NS110707 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LIU, YING · 2019 to 2023
$1.7M
NIA NIH HHS R01 AG064579NIA NIH HHS R01 AG073779NINDS NIH HHS R01 NS110707NINDS NIH HHS R01 NS122108NINDS NIH HHS RF1 NS128800
6 · The paper itself

Abstract

Progressive neuronal loss is a hallmark of many neurological disorders, yet the adult human brain has a limited capacity for endogenous neuronal replacement. Direct neuronal reprogramming represents an alternative strategy for generating new neurons. Microglia, the brain's resident immune cells, are uniquely positioned as candidate cellular substrates due to their abundance, self-renewal capacity, high motility, and rapid recruitment to sites of injury. Here, using live-cell imaging and electrophysiological recordings, we show that human pluripotent stem cell (hPSC)-derived primitive macrophage progenitors (PMPs) and their microglial derivatives exhibit neuronal reprogramming competence. Inducible expression of NEUROG2 in hPSC-derived PMPs drives acquisition of neuronal morphology, sequential expression of early and mature neuronal markers, organization of synaptic proteins, and functional excitability characterized by action potential firing. Single-nucleus RNA sequencing reveals a continuous, directionally ordered reprogramming trajectory marked by suppression of myeloid transcriptional programs, progression through intermediate remodeling states, and progressive activation of neuronal gene regulatory networks, consistent with a regulated lineage conversion rather than partial identity switching. Using a xenotransplantation-based human microglia chimeric brain model, we further demonstrate that inducible NEUROG2 expression reprograms donor-derived human microglia toward a neuronal identity

Identifiers

PMID41890087
PMCPMC13015545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.